Radius Health on Thursday outlined its case in a presentation meant to convince investors to support a deal the company reached last month to sell itself for up to $890 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,